Molecularly-Targeted Therapy
Showing 1 - 25 of >10,000
Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular
Completed
- Gliosarcoma
- Recurrent Glioblastoma
- Laboratory Biomarker Analysis
- +2 more
-
Chicago, IllinoisNorthwestern University
Aug 5, 2022
Evidence Determining Individualized Cancer Therapy for Incurable
Terminated
- Hematologic Cancer
- Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)
-
La Jolla, CaliforniaUCSD Moore's Cancer Center
Jan 31, 2022
EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,
Terminated
- EGFR Activating Mutation
- +2 more
- Chemotherapy
- +6 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jan 28, 2021
Colorectal Cancer, Resectable Colorectal Carcinoma Trial in Milan (Trastuzumab deruxtecan, Durvalumab, Panitumumab)
Active, not recruiting
- Colorectal Cancer
- Resectable Colorectal Carcinoma
- Trastuzumab deruxtecan
- +4 more
-
Milan, Lombardia/MI, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 26, 2023
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon Trial in United States (afatinib,
Completed
- Non-small Cell Lung Carcinoma
- +3 more
- afatinib
- +2 more
-
Denver, Colorado
- +7 more
Aug 17, 2022
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Breast Cancer, Metastatic Cancer Trial in Shanghai (SHR7390, Famitinib, SHR3162)
Recruiting
- Breast Cancer
- Metastatic Cancer
- SHR7390
- +14 more
-
Shanghai, Shanghai, ChinaCancer Hospital Affiliated to Fudan University
Jul 22, 2022
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (other, drug, procedure)
Completed
- Recurrent Melanoma
- +4 more
- cytology specimen collection procedure
- +4 more
-
Scottsdale, Arizona
- +7 more
Dec 16, 2019
Targeted Therapy to Increase RAI Uptake in Metastatic PTC
Recruiting
- Papillary Thyroid Cancer
- Pediatric Cancer
- Whole body scan
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 11, 2022
Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)
Not yet recruiting
- Early-stage Breast Cancer
- Atezolizumab 1200 mg in 20 ML Injection
- +5 more
-
Heidelberg, Baden-Wuerttemberg, GermanyNational Center for Tumor Diseases
Sep 13, 2022
Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)
Recruiting
- Relapse/Refractory Multiple Myeloma
- DeepTag-GPRC5D Targeted CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023
Pulmonary Hypertension Trial
Not yet recruiting
- Pulmonary Hypertension
- (no location specified)
Nov 12, 2023
Efficacy of Targeted Therapy for NSCLC
Recruiting
- Evaluation
- +2 more
- RecistTM criteria
-
Chongqing, Chongqing, ChinaCancer Center, Dapping Hospital, Army Medical Center of PLA
Nov 15, 2023
Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR
Completed
- Metastatic Colorectal Adenocarcinoma
- (no location specified)
Oct 9, 2023
Nightmares, REM-Sleep Type, PTSD Trial in Geneva (Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep,
Recruiting
- Nightmares, REM-Sleep Type
- PTSD
- Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep
- Imagery Rehearsal Therapy
-
Geneva, SwitzerlandCenter for Sleep Medicine
Jul 7, 2023
Node-positive Breast Cancer Trial (Targeted axillary lymph node dissection)
Not yet recruiting
- Node-positive Breast Cancer
- Targeted axillary lymph node dissection
- (no location specified)
Jan 6, 2023
Heart Transplant Rejection Trial in Helsinki (Cell-free DNA)
Recruiting
- Heart Transplant Rejection
- Cell-free DNA
-
Helsinki, Uusimaa, FinlandHelsinki University Hospital
Oct 2, 2023
Polycystic Ovary Syndrome Trial in Hyderabad (laparoscopy / laparotomy, NO INTERVENTION)
Not yet recruiting
- Polycystic Ovary Syndrome
- laparoscopy / laparotomy
- NO INTERVENTION
-
Hyderabad, Telangana, IndiaDr. Shraddha Ramchandani
Oct 25, 2023
Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)
Recruiting
- Solid Tumor
- Haematological Malignancy
- Alectinib
- +4 more
-
Belfast, United Kingdom
- +24 more
Jan 31, 2023
Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
- +4 more
-
Guangzhou, Guangdong, ChinaSUN Yat-sen University Cancer Center
Sep 11, 2023
Prostate Cancer Stage I Trial in Torino (Katty focal therapy)
Completed
- Prostate Cancer Stage I
- Katty focal therapy
-
Torino, TO, ItalyA.O.U. San Giovanni Battista Molinette
Jan 31, 2023
Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)
Not yet recruiting
- Locally Advanced Unresectable Pancreatic Adenocarcinoma
- Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
- (no location specified)
Jun 25, 2023